HLN
Haleon plcNYSEHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$39.99B
P/E Ratio
18.04
EPS
$0.50
Beta
0.25
52W High
$11.20
52W Low
$8.60
50-Day MA
$9.76
200-Day MA
$9.79
Dividend Yield
0.78%
Profit Margin
15.10%
Forward P/E
16.75
PEG Ratio
2.36
About Haleon plc
Haleon plc (HLN) is a prominent global player in the consumer health sector, dedicated to providing innovative health solutions through its diverse portfolio, which includes renowned brands like Sensodyne, Panadol, and Voltaren. Established as a spin-off from GlaxoSmithKline, the company leverages its strong brand equity to cater to critical health segments such as oral care, pain relief, and dietary supplements. Committed to sustainability and consumer-centric innovation, Haleon is strategically positioned to enhance health outcomes worldwide while pursuing growth and generating value for its shareholders through targeted investments and continuous product development.
Fundamentals
| Revenue (TTM) | $11.03B |
| Gross Profit (TTM) | $7.14B |
| EBITDA | $2.74B |
| Operating Margin | 23.20% |
| Return on Equity | 10.30% |
| Return on Assets | 4.67% |
| Revenue/Share (TTM) | $2.46 |
| Book Value | $4.99 |
| Price-to-Book | 1.81 |
| Price-to-Sales (TTM) | 3.63 |
| EV/Revenue | 3.329 |
| EV/EBITDA | 12.85 |
| Quarterly Earnings Growth (YoY) | 92.00% |
| Quarterly Revenue Growth (YoY) | 0.60% |
| Shares Outstanding | $4.43B |
| Float | $8.86B |
| % Insiders | 0.01% |
| % Institutions | 13.44% |
Historical Volatility
HV 10-Day
20.11%
HV 20-Day
20.02%
HV 30-Day
17.04%
HV 60-Day
25.06%
HV Rank
11.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($11.74 target)
2
Strong Buy1
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/14/2026